News

This article was originally published by Cancer Network The FDA has approved daratumumab (Darzalex) for use in combination with carfilzomib...

This article was originally published by Targeted Oncology As part of a virtual Case Based Peer Perspective event, Jesus G. Berdeja, MC, director of...

This article was originally published by AJMC MRD Should Be More Widely Used in Clinical Care of MM, Report Argues Advances in scientists'...

This article was originally published by Cancer Health New drugs to treat multiple myeloma are producing better results for patients, with fewer...

This article was originally published by Targeted Oncology. C. Ola Landgren, MD, PhD, chief of Myeloma Service and hematologic oncologist at...

Blenrep, an antibody-drug conjugate, is the first drug approved for multiple myeloma that targets the antigen BCMA. Several other companies are also...

For many patients with multiple myeloma, a new generation of drugs and drug combinations is producing better outcomes and fewer side effects. In...

This article was originally published by Cancer Therapy Advisor Researchers have used deep whole-genome sequencing (WGS) to identify genomic markers...

This was originally published by AJMC Severe renal impairment (RI) is associated with decreased rates of survival among patients with multiple...

This article was originally published by Cancer Therapy Advisor Receipt of dialysis may be a risk factor for inpatient mortality in patients with...